Benzinga What's Going On With AIM ImmunoTech Stock Friday?
AIM ImmunoTech (AMEX: AIM) sees bullish momentum after final patent approval in Japan for its Ampligen-based oncology treatments. Importance Rank: 1 read more
AIM ImmunoTech (AMEX: AIM) sees bullish momentum after final patent approval in Japan for its Ampligen-based oncology treatments. Importance Rank: 1 read more